RecruitingVirtual RealityDexmedetomidineMaternal Anxiety
Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes During Cesarean Section
Eligible age
18+ yrs
Accepts
Women
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study aims to compare the efficacy of intravenous dexmedetomidine infusion versus virtual reality (VR) in reducing maternal anxiety, stress, and hemodynamic instability during cesarean section and their effects on neonatal outcome as respiration and heart rate.
Sponsor: Benha University
You may qualify if…
- ✓ Age over 18 years old.
- ✓ American Society of Anesthesiologists (ASA) physical status II.
- ✓ Scheduled for elective cesarean section (CS) delivery under Central Neuraxial Blockade.
- ✓ Provide informed consent and agree to participate in the study.
You may not qualify if…
- ✕ Patient's refusal
- ✕ Patient known have contraindications for Regional Anesthesia as infection at the site of injection, severe coagulopathy or allergy to local anesthetics.
- ✕ Patient with psychiatric disorders.
- ✕ Sensory impairment (blindness, deafness).
- ✕ Any technical problem preventing proper fitting of the glasses to the patient face.
- ✕ Patients with cognitive impairment, epilepsy or with claustrophobia
- ✕ Patients with suspected eye infection
- ✕ Signs of active labor.
Source: ClinicalTrials.gov · NCT07343843 · last updated 2026-01-21